1. Mass spectrometry based strategy for studies of binding sites and structural changes of cisplatin binding to myoglobin
- Author
-
Huan Liu, Shuying Liu, Ningbo Zhang, Meng Cui, and Zhiqiang Liu
- Subjects
inorganic chemicals ,0301 basic medicine ,Cisplatin ,medicine.diagnostic_test ,Proteolysis ,Electrospray ionization ,010401 analytical chemistry ,Organic Chemistry ,Mass spectrometry ,Tandem mass spectrometry ,01 natural sciences ,0104 chemical sciences ,Analytical Chemistry ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,Myoglobin ,chemistry ,Biochemistry ,medicine ,Binding site ,Heme ,Spectroscopy ,medicine.drug - Abstract
Rationale It is of great significance to investigate the interaction of the metallodrug cisplatin (cis-[PtCl2 (NH3 )2 ]) with myoglobin for understanding of the mechanism of action of cisplatin and the overexpression of myoglobin in tumor cells. Methods The reactions of cisplatin and myoglobin were incubated under different conditions. A mass spectrometry (MS)-based strategy combining full proteolysis and limited proteolysis was developed for comprehensive studies of cisplatin-myoglobin interaction. Results The binding sites of cisplatin on myoglobin were identified as Trp14, His64, His81, His113 and His116 using electrospray ionization multiple-stage tandem mass spectrometry (ESI-MSn ) without liquid chromatography (LC) separation. The relative abundances of digested peptides from platinated myoglobin were obviously higher than those from native samples by limited proteolysis. Conclusions An alternative and simple approach was developed to successfully monitor conformational changes of myoglobin induced by cisplatin binding using an ESI-MS-based quantification method combined with limited proteolysis. Meanwhile, His64 was firstly found to coordinate to platinum, which was likely to affect hydrogen bonds with the oxygen in the heme group. Copyright © 2016 John Wiley & Sons, Ltd.
- Published
- 2016